Medically reviewed by Renita White, MD Mouth and tongue lesions are often one of the first symptoms of human immunodeficiency ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

New York State Assemblymember Zohran Mamdani, 33, shocked political observers with his likely upset of former Gov. Andrew ...

After contracting HIV in the early ’90s, Teresita became more vocal about HIV/AIDS, talking about prevention and available treatment during her performances. “We needed her as one of our elders to ...

Drawing from 19 studies across sub-Saharan Africa and select global contexts, the review finds that RHIS remain largely ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

Elevated immune and neuronal injury markers in MSM with HIV and PrEP suggest lifestyle factors, beyond HIV, drive persistent ...

Hypertension, cigarette smoking, reduced high-density lipoprotein cholesterol, and HIV viral load were modifiable risk factors for primary MACE in patients with HIV on ART.

Patients with HIV receiving 3-drug ART with BIC/FTC/TAF exhibited low rates of viremia, particularly those with high treatment adherence.

According to the UNAIDS Spectrum Report 2024, approximately 360,000 people are currently living with HIV in Botswana.